Loading
Latest filing published 04 Dec 2024 for Aquestive Therapeutics, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Douglas K. Bratton (board member) discloses dealings in 2 companies, chiefly Midwest Holding Inc. and Aquestive Therapeutics, Inc. The record holds 3 filings, for trades running from 11 November 2021 to 2 December 2024.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 4 December 2024 came the latest disclosure, a transaction in Aquestive Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations